Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Leaflet RELVAR ELLIPTA 92mcg / 22mcg inhalation powder
- Product code:
- W60399001
- Quantity:
- 1
- Indicated for:
- asthma; chronic obstructive pulmonary disease
- Route of administration:
- inhalation
- Substance:
- fluticasone + vilanterol (glucocorticoid + beta-2 adrenergic agonist)
- ATC
- R03AK10 — Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
Precautions:
Hyperglycemia
This medicine may increase blood sugar.
Immunosuppression / infection risk
This medicine may increase the risk of infections.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
The combination of fluticasone and vilanterol is indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Fluticasone acts as a corticosteroid, reducing airway inflammation, while vilanterol is a long-acting bronchodilator that helps relax bronchial muscles and improve breathing.
The medication is administered by inhalation, usually once a day at the same time, as directed by your doctor. Regular use is essential to maintain symptom control and prevent asthma attacks or COPD exacerbations.
Side effects may include throat irritation, oral infections, headache, or palpitations. Rarely, severe allergic reactions or worsening of respiratory symptoms may occur. If you experience difficulty breathing or facial swelling, contact your doctor immediately.
The combination of fluticasone and vilanterol is effective in managing asthma and COPD, but correct use and medical monitoring are necessary to ensure the safety and effectiveness of the treatment.
The medication is administered by inhalation, usually once a day at the same time, as directed by your doctor. Regular use is essential to maintain symptom control and prevent asthma attacks or COPD exacerbations.
Side effects may include throat irritation, oral infections, headache, or palpitations. Rarely, severe allergic reactions or worsening of respiratory symptoms may occur. If you experience difficulty breathing or facial swelling, contact your doctor immediately.
The combination of fluticasone and vilanterol is effective in managing asthma and COPD, but correct use and medical monitoring are necessary to ensure the safety and effectiveness of the treatment.
General data about RELVAR ELLIPTA 92mcg / 22mcg
- Substance:
- fluticasone + vilanterol
- Date of latest medicines list:
- 01-07-2015
- Product code:
- W60399001
- Concentration:
- 92mcg / 22mcg
- Pharmaceutical form:
- inhalation powder
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for fluticasone + vilanterol
- 184mcg/22mcg
- 92mcg/22mcg